Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine in Children Aged 6 Months to 17 Years
Phase of Trial: Phase III
Latest Information Update: 15 Feb 2019
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors sanofi pasteur
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 10 Apr 2018 Planned End Date changed from 4 Sep 2018 to 30 Aug 2018.
- 08 Feb 2018 Status changed from recruiting to active, no longer recruiting.